News
ENTX
1.240
-2.36%
-0.030
Weekly Report: what happened at ENTX last week (0511-0515)?
Weekly Report · 6d ago
Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Entera Bio (ENTX) and Merck & Company (MRK)
TipRanks · 05/11 10:20
Weekly Report: what happened at ENTX last week (0504-0508)?
Weekly Report · 05/11 09:08
Entera Bio GAAP EPS of -$0.07 beats by $0.02
Seeking Alpha · 05/11 06:44
Entera Bio Faces Elevated Operational Risks Amid Escalating Middle East Geopolitical Tensions
TipRanks · 05/10 06:01
Entera Bio files to sell 19.57M ordinary shares for holders
TipRanks · 05/08 22:57
Entera Bio Highlights Q1 2026 Progress and Financing
TipRanks · 05/08 20:53
Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs
Barchart · 05/08 15:05
Weekly Report: what happened at ENTX last week (0427-0501)?
Weekly Report · 05/04 09:08
Entera Bio Price Target Cut to $9.00/Share From $10.00 by HC Wainwright & Co.
Dow Jones · 04/27 11:53
Entera Bio Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 04/27 11:53
HC Wainwright & Co. Maintains Buy on Entera Bio, Lowers Price Target to $9
Benzinga · 04/27 11:43
Entera Bio price target lowered to $9 from $10 at H.C. Wainwright
TipRanks · 04/27 10:12
Weekly Report: what happened at ENTX last week (0420-0424)?
Weekly Report · 04/27 09:08
Weekly Report: what happened at ENTX last week (0413-0417)?
Weekly Report · 04/20 09:08
Entera Bio to Host Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613
Barchart · 04/14 07:45
Weekly Report: what happened at ENTX last week (0406-0410)?
Weekly Report · 04/13 09:08
Greenberg Traurig Represents Israel-based Entera Bio in $10M Private Placement Led by BVF Partners
PR Newswire · 04/06 17:50
Entera Bio Prices $10 Mln Private Placement Of Shares And Warrants; Stock Down
NASDAQ · 04/06 10:20
Weekly Report: what happened at ENTX last week (0330-0403)?
Weekly Report · 04/06 09:08
More
Webull provides a variety of real-time ENTX stock news. You can receive the latest news about Entera Bio Ltd through multiple platforms. This information may help you make smarter investment decisions.
About ENTX
Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.